The purpose of the study is to measure the difference in the proportion of participants with prespecified patient management actions between a tested interventional group and a control group.
Primary care physician (PCPs): physicians such as family medicine practitioners and internists who do not specialize in neurological care.
Secondary care physicians (SCPs): physicians such as geriatricians or neurologists who see patients for specific reasons.
Tertiary care physicians (TCPs): specialty neurologists who focus on certain neurological conditions.
Group 1: PCPs who routinely evaluate and manage patients over the age of 50 in a family practice or internist setting.
In the 18 months prior to identification have prior or associated HCP-ordered referral or prior prescription of drug therapies, for the SCIC
Participants with previous amyloid- or tau-specific tests, defined as
Amyloid position emission tomography (PET)
Tau PET